go back

Melanoma Versus Benign Mole Gene Test

Alaska rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $6,607 · 10th–90th $1,950$15,1360%20%10th90th$6,607Professionalmedian $4,365 · 10th–90th $1,380$6,6070%20%10th90th$4,365$2.0K$5.0K$10.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$13,489.63
Median
$14,125.38
Typical High
$22,908.68
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,380.38
Median
$6,606.93
Typical High
$6,606.93
Cigna
Setting
Facility
Modifier
Global
Typical Low
$5,370.32
Median
$5,370.32
Typical High
$5,370.32
Moda Health
Setting
Facility
Modifier
Global
Typical Low
$1,949.84
Median
$1,949.84
Typical High
$6,606.93
Moda Health
Setting
Professional
Modifier
Global
Typical Low
$1,949.84
Median
$1,949.84
Typical High
$6,309.57
Premera BCBS
Setting
Facility
Modifier
Global
Typical Low
$1,949.84
Median
$7,244.36
Typical High
$7,762.47
Premera BCBS
Setting
Professional
Modifier
Global
Typical Low
$2,951.21
Median
$4,365.16
Typical High
$4,365.16
Providence
Setting
Facility
Modifier
Global
Typical Low
$1,548.82
Median
$5,370.32
Typical High
$9,332.54
United
Setting
Professional
Modifier
Global
Typical Low
$1,174.90
Median
$1,949.84
Typical High
$5,888.44